Gainers
- Kiora Pharmaceuticals KPRX shares rose 14.7% to $1.95 during Thursday's after-market session. At the close, Kiora Pharmaceuticals's trading volume reached 6.7 million shares. This is 822.5% of its average volume over the last 100 days. The company's market cap stands at $24.6 million.
- Lexicon Pharmaceuticals LXRX stock rose 8.39% to $4.52. At the close, Lexicon Pharmaceuticals's trading volume reached 79.9K shares. This is 11.2% of its average volume over the last 100 days. The market value of their outstanding shares is at $673.0 million.
- Aileron Therapeutics ALRN stock moved upwards by 3.9% to $0.56. The market value of their outstanding shares is at $50.4 million.
- Altimmune ALT shares moved upwards by 3.58% to $9.25. Today's trading volume for this security ended up closing at 64.9K shares, which is 7.7 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $367.5 million.
- China SXT Pharmaceuticals SXTC shares moved upwards by 2.94% to $0.7. China SXT Pharmaceuticals's trading volume hit 53.9K shares by close, accounting for 10.6% of its average volume over the last 100 days. The market value of their outstanding shares is at $10.8 million.
- Sonnet BioTherapeutics SONN shares increased by 2.93% to $0.43. The market value of their outstanding shares is at $26.1 million.
Losers
- Kaleido Biosciences KLDO stock fell 5.7% to $2.5 during Thursday's after-market session. The market value of their outstanding shares is at $106.4 million.
- Marker Therapeutics MRKR stock decreased by 4.54% to $0.95. The market value of their outstanding shares is at $78.9 million.
- Mereo BioPharma Group MREO stock decreased by 4.35% to $1.54. The market value of their outstanding shares is at $167.7 million.
- PDS Biotechnology PDSB stock decreased by 4.04% to $7.85. The market value of their outstanding shares is at $223.2 million.
- Surface Oncology SURF stock declined by 3.5% to $4.69. The company's market cap stands at $216.3 million.
- Lixte Biotech Holdings LIXT shares declined by 3.48% to $1.11. The company's market cap stands at $15.2 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in